SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is trending as investors express significant frustration and skepticism toward the Board's decision to accept an all-cash acquisition offer, which many feel drastically undervalues the company's cash position, core drug assets, and future growth potential. The community is actively debating the merits of the deal, with some shareholders organizing to oppose the tender offer and others seeking legal avenues to challenge what they characterize as an unethical 'fire sale' by management.

YD Bio Ltd. is a biotechnology company building an integrated healthcare platform across regulated diagnostics, clinical services, and commercial healthcare markets. It operates DNA methylation–based oncology testing programs under an LDT-first strategy and provides compliant life science distribution and clinical trial supply chain services to pharmaceutical and biotechnology partners. The company’s offerings include cancer detection products, regenerative ophthalmology solutions, and exosome-based technologies. YD Bio was founded on February 6, 2024 and is headquartered in Taipei, Taiwan.

YD Bio Ltd.

YDES is currently garnering significant attention from retail traders due to its status as a recent Nasdaq uplisting with a remarkably low float, leading to discussions about potential volatility and short-squeeze setups. The community is closely monitoring the stock's price action alongside its associated warrants, debating whether current valuations present a mispricing opportunity or a speculative trap.

MMTec, Inc. engages in the holding of an equity interest in MM Future. It operates through the Gujia, MM Future and HC Securities and MM Global. The Gujia, MM Future and HC Securities segment provide market data services and consulting services. The MM Global segment is involved in introducing a broker that clears all transactions through a clearing broker dealer and earns commission income, placement agent services fee, and other related income from customers. The company was founded on January 4, 2018 and is headquartered in Hong Kong.

Mmtec Inc

Mmtec Inc is generating significant market interest as traders speculate on potential short squeeze dynamics and the company's efforts to maintain its NASDAQ listing status. Community discussions are heavily focused on the stock's extreme volatility and its tendency to mirror past microcap momentum plays, with participants actively debating the risks of delisting against the possibility of aggressive rallies.

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

LENSAR Inc

LENSAR Inc. shares are under significant pressure following the mutual termination of its merger agreement with Alcon, a decision prompted by mounting regulatory opposition from the FTC. The community is actively debating the company's standalone future, weighing concerns over operational liquidity and intense market competition against the potential durability of its recurring revenue model and ALLY system adoption.

Syntec Optics Holdings, Inc. engages in the design and manufacture of optics and photonics enabled products. The company was founded in 1981 and is headquartered in Rochester, NY.

Syntec Optics Holdings Inc. - Ordinary Shares - Class A

Syntec Optics Holdings Inc

Syntec Optics is seeing intense retail interest as investors focus on its role as a specialized supplier for U.S. defense programs and high-growth AI infrastructure. The community is actively debating the stock's low float and strong insider ownership, with many monitoring for potential momentum breakouts tied to ongoing government contract announcements.

Ethereum Classic

Ethereum Classic is experiencing renewed community focus as investors speculate on a long-awaited breakout, with many sentiment-driven discussions highlighting the contrast between the token's historical performance and its current suppressed price action. Traders are actively debating the timing of a potential trend reversal, frequently citing broader crypto market catalysts and comparing its utility to other established proof-of-work assets.

Maulcoin

Maulcoin is trending as the community celebrates the restoration of its ticker symbol and anticipates the upcoming release of a price chart. Supporters are actively engaging in community-led growth strategies, framing the project as an honest, long-term alternative to typical pump-and-dump meme coins.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is seeing intense community debate following a weak earnings report, with investors expressing frustration over the lack of capital deployment and the stock's underperformance compared to the broader market. While some shareholders are calling for dividends or aggressive buybacks to counter the stagnation, others remain focused on the company's massive cash pile as a potential defensive play during ongoing geopolitical uncertainty.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as a long-standing satirical project that has transitioned onto the Solana network, with the community positioning it as a cultural successor to early Bitcoin lore. Supporters are actively discussing its 15-year history and perceived potential for generational wealth, while debates continue between those dismissing it as a meme-driven joke and those convinced it represents a unique opportunity in the current market cycle.

WorldFinancial

WLFI is currently facing significant volatility and intense community debate as investors react to congressional scrutiny regarding the project's foreign investment ties and its relationship with the Trump administration. While some participants view the current price action as a strategic accumulation opportunity ahead of upcoming industry forums, others express concern over token dilution, governance transparency, and the potential for the project to follow the downward trajectory of past politically-linked assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MBX Biosciences (NASDAQ:MBX) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered MBX Biosciences from a "hold" rating to a "sell" rating in a research report on Saturday...

MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - What's Next?

MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - Time to Buy...

Lifesci Capital Weighs in on MBX Biosciences Q1 Earnings

MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) - Analysts at Lifesci Capital issued their Q1 2026 earnings estimates for MBX Biosciences in a report released on Tuesday, March 31st. Lifesci Capital analyst P. Dolezal anticipates that the company will post earnings of ($0.66) per share for the quar...

MBX Biosciences (NASDAQ:MBX) Upgraded at Lifesci Capital

Lifesci Capital raised MBX Biosciences to a "strong-buy" rating in a report on Tuesday...

MBX Biosciences (NASDAQ:MBX) Shares Up 8.5% - What's Next?

MBX Biosciences (NASDAQ:MBX) Stock Price Up 8.5% - What's Next...

MBX Biosciences, Inc. (NASDAQ:MBX) Sees Large Increase in Short Interest

MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 2,983,725 shares, a growth of 24.6% from the February 26th total of 2,395,339 shares. Based on an average...

221,672 Shares in MBX Biosciences, Inc. $MBX Acquired by Goelzer Investment Management Inc.

Goelzer Investment Management Inc. acquired a new position in shares of MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 221,672 shares of the company's stock, valued at approximately...

MBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should Know

Key PointsThe president & CEO of MBX Biosciences reported the acquisition of 18,500 indirectly held shares for about $526,000 on March 13, 2026...

MBX Biosciences, Inc. (NASDAQ:MBX) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of MBX Biosciences, Inc. (NASDAQ:MBX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twelve research firms that are presently covering the company...

Hudson Bay Capital Management LP Purchases New Stake in MBX Biosciences, Inc. $MBX

Hudson Bay Capital Management LP bought a new position in MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm bought 85,000 shares of the company's stock, valued at approximately $1,488,000. Hudson Bay Capital Managem...

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

Current Price	$31.00
Prev Close	$32.86
Open	$33.24
Dividend Yield	0.00%
50-Day Moving Average	$32.86
Beta	1.59
Avg. Volume	526,515.84
PE Ratio	-12.82

52-Week High	$44.89
52-Week Low	$6.81
Market Capitalization	$1.56B
EPS (Annual)	-$2.38
Price to Book	3.77
Revenue Per Employee	$0.00

MBX
MBX Biosciences Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MBX News

MBXMBX Biosciences Inc.